A carregar...

Safety and efficacy of hydroxyurea in children and adolescents with sickle/beta-thalassemia: two-year experience

BACKGROUND: Hydroxyurea is a cytotoxic and myelosuppressive drug that has been used during recent years in the treatment of children with severe sickle cell disease. Nevertheless, questions remain regarding its role in young patients with no severe course, like sickle/beta-thalassemia (S/b-thal) pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hippokratia
Main Authors: Papadopoulou, E, Teli, A, Theodoridou, S, Gompakis, N, Economou, M
Formato: Artigo
Idioma:Inglês
Publicado em: SOCIETY OF "FRIENDS OF HIPPOKRATIA JOURNAL" 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4938110/
https://ncbi.nlm.nih.gov/pubmed/27418768
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!